Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | P2RY1 | P47900 | 14/20 | 0.77 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diflufenican SCHEMBL22023 | 1.00 | KMT2A (1.00) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| Diflufenican SCHEMBL29373740 | 1.00 | KMT2A (1.00) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| Diflufenican SCHEMBL8536896 | 1.00 | KMT2A (1.00) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| Diflufenican SCHEMBL28864547 | 0.96 | KMT2A (0.93) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| Diflufenican SCHEMBL21295280 | 0.94 | KMT2A (0.88) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| Diflufenican SCHEMBL7534513 | 0.91 | KMT2A (0.83) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| SCHEMBL10968288 | 0.90 | KDM4E (0.81) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| SCHEMBL10970533 | 0.90 | KMT2A (0.81) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| SCHEMBL9616229 | 0.88 | KMT2A (0.79) | KMT2AKDM4EMEN1CYP1A2CYP2C19 | |
| SCHEMBL10968980 | 0.88 | KDM4E (0.79) | KMT2AKDM4EMEN1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707391-A1 | NUCLEIC ACID COMPOUNDS FOR ZPI INHIBITION | e-therapeutics PLC (GB) | 2026-03-11 | — | — | EP | disclosed |